Literature DB >> 17828815

Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection.

Christoph Neumann-Haefelin1, Hans-Christian Spangenberg, Hubert-E Blum, Robert Thimme.   

Abstract

Virus-specific CD8+ T cells are thought to be the major anti-viral effector cells in hepatitis C virus (HCV) infection. Indeed, viral clearance is associated with vigorous CD8+ T cell responses targeting multiple epitopes. In the chronic phase of infection, HCV-specific CD8+ T cell responses are usually weak, narrowly focused and display often functional defects regarding cytotoxicity, cytokine production, and proliferative capacity. In the last few years, different mechanisms which might contribute to the failure of HCV-specific CD8+ T cells in chronic infection have been identified, including insufficient CD4+ help, deficient CD8+ T cell differentiation, viral escape mutations, suppression by viral factors, inhibitory cytokines, inhibitory ligands, and regulatory T cells. In addition, host genetic factors such as the host's human leukocyte antigen (HLA) background may play an important role in the efficiency of the HCV-specific CD8+ T cell response and thus outcome of infection. The growing understanding of the mechanisms contributing to T cell failure and persistence of HCV infection will contribute to the development of successful immunotherapeutical and -prophylactical strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17828815      PMCID: PMC4611762          DOI: 10.3748/wjg.v13.i36.4839

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  117 in total

1.  Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Authors:  Natalia Paladino; Hugo Fainboim; Graciela Theiler; Teresa Schroder; Alberto Eduardo Muñoz; Ana Claudia Flores; Omar Galdame; Leonardo Fainboim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.

Authors:  A J Weiner; X Paliard; M J Selby; A Medina-Selby; D Coit; S Nguyen; J Kansopon; C L Arian; P Ng; J Tucker; C T Lee; N K Polakos; J Han; S Wong; H H Lu; S Rosenberg; K M Brasky; D Chien; G Kuo; M Houghton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

Authors:  D K Wong; D D Dudley; N H Afdhal; J Dienstag; C M Rice; L Wang; M Houghton; B D Walker; M J Koziel
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  Protection against persistence of hepatitis C.

Authors:  Shruti H Mehta; Andrea Cox; Donald R Hoover; Xiao-Hong Wang; Qing Mao; Stuart Ray; Steffanie A Strathdee; David Vlahov; David L Thomas
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

5.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

Authors:  Pablo Sarobe; Juan José Lasarte; Noelia Casares; Ascensión López-Díaz de Cerio; Elena Baixeras; Pablo Labarga; Nicolás García; Francisco Borrás-Cuesta; Jesús Prieto
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.

Authors:  Christine Rollier; Joost A R Drexhage; Babs E Verstrepen; Ernst J Verschoor; Ronald E Bontrop; Gerrit Koopman; Jonathan L Heeney
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

9.  Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

Authors:  Randy S Longman; Andrew H Talal; Ira M Jacobson; Matthew L Albert; Charles M Rice
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  20 in total

1.  Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.

Authors:  Cordelia Manickam; Premeela Rajakumar; Lynn Wachtman; Joshua A Kramer; Amanda J Martinot; Valerie Varner; Luis D Giavedoni; R Keith Reeves
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.

Authors:  Rowena A Bull; Preston Leung; Silvana Gaudieri; Pooja Deshpande; Barbara Cameron; Melanie Walker; Abha Chopra; Andrew R Lloyd; Fabio Luciani
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Ineffective CD8(+) T-cell immunity to adeno-associated virus can result in prolonged liver injury and fibrogenesis.

Authors:  Jessica Spahn; Robert H Pierce; Ian N Crispe
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

Review 4.  Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Authors:  Jason Grebely; Maria Prins; Margaret Hellard; Andrea L Cox; William O Osburn; Georg Lauer; Kimberly Page; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Infect Dis       Date:  2012-05       Impact factor: 25.071

Review 5.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

6.  Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

7.  Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.

Authors:  Enass A Abdel-Hameed; Susan D Rouster; Hong Ji; Ashley Ulm; Helal F Hetta; Nadeem Anwar; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  Viral Immunol       Date:  2016-02-17       Impact factor: 2.257

8.  Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.

Authors:  Maria Nikolova; Jean-Daniel Lelievre; Matthieu Carriere; Armand Bensussan; Yves Lévy
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

9.  Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake.

Authors:  Polyxeni P Doumba; Elisavet Serti; Maria Boutsikou; Manousos M Konstadoulakis; Urania Georgopoulou; John Koskinas
Journal:  Cell Mol Life Sci       Date:  2013-05-05       Impact factor: 9.261

Review 10.  T-cell responses in hepatitis B and C virus infection: similarities and differences.

Authors:  Julia Schmidt; Hubert E Blum; Robert Thimme
Journal:  Emerg Microbes Infect       Date:  2013-03-27       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.